I agree that this site is using cookies. You can find further informations here.
X
Rojavin, Mikhail
76  results:
Search for persons X
?
1

Systemic IgG Exposure and Safety in Patients with Primary I..:

Wasserman, Richard L ; Cunningham-Rundles, Charlotte ; Anderson, John...
Immunotherapy.  14 (2022)  16 - p. 1315-1328 , 2022
Link: https://doi.org/10.2217/..
 
?
2

Safety and Tolerability of Subcutaneous IgPro20 at High Inf..:

Anderson, John T. ; Bonagura, Vincent R. ; Cowan, Juthaporn...
Journal of Clinical Immunology.  41 (2021)  2 - p. 458-469 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Safety and tolerability of IgPro10 in Japanese primary immu..:

Morio, Tomohiro ; Gotoh, Kenji ; Imagawa, Tomoyuki...
International Journal of Hematology.  113 (2021)  6 - p. 921-929 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Safety and Tolerability of Manual Push Administration of Su..:

Cowan, Juthaporn ; Bonagura, Vincent R. ; Lugar, Patricia L....
Journal of Clinical Immunology.  41 (2020)  1 - p. 66-75 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Pharmacometric Analysis of IgPro10 in Japanese and Non-Japa..:

Luo, Dandan ; Baheti, Gautam ; Tortorici, Michael A...
Clinical Therapeutics.  42 (2020)  1 - p. 196-209.e5 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Safety Profile of High IgPro20 Infusion Parameters in Patie..:

Rojavin, Mikhail ; Hu, Chengping ; Anderson, John...
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB32 , 2020
Link: https://doi.org/10.1016/..
 
?
7

Population pharmacokinetic analysis of weekly and biweekly ..:

Zhang, Ying ; Baheti, Gautam ; Chapdelaine, Hugo...
International Immunopharmacology.  81 (2020)  - p. 106005 , 2020
Link: https://doi.org/10.1016/..
 
?
8

Feasibility of Subcutaneous IgPro20 Administration via Manu..:

Cowan, Juthaporn ; Bonagura, Vincent ; Hu, Chengping...
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB217 , 2020
Link: https://doi.org/10.1016/..
 
?
9

The HILO Study: High Volumes and Flow Rates of Subcutaneous..:

Anderson, John ; Bonagura, Vincent ; Cowan, Juthaporn...
Journal of Allergy and Clinical Immunology.  145 (2020)  2 - p. AB216 , 2020
Link: https://doi.org/10.1016/..
 
?
10

Tolerability of Higher Than Current Infusion Rate and Volum..:

Rojavin, Mikhail A. ; Hofmann, Jutta ; Praus, Michaela
Journal of Allergy and Clinical Immunology.  143 (2019)  2 - p. AB114 , 2019
Link: https://doi.org/10.1016/..
 
?
11

Pharmacokinetic properties of Privigen® in Japanese patient..:

Morio, Tomohiro ; Baheti, Gautam ; Tortorici, Michael A...
Immunological Medicine.  42 (2019)  4 - p. 162-168 , 2019
Link: https://doi.org/10.1080/..
 
?
12

Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 ..:

Rojavin, Mikhail A. ; Chapdelaine, Hugo ; Tortorici, Michael A....
Clinical Pharmacology in Drug Development.  9 (2019)  6 - p. 664-670 , 2019
Link: https://doi.org/10.1002/..
 
?
13

Privigen® has similar pharmacokinetic properties in primary..:

Tortorici, Michael A. ; Lawo, John-Philip ; Weide, Rudolf...
International Immunopharmacology.  66 (2019)  - p. 119-126 , 2019
Link: https://doi.org/10.1016/..
 
?
14

Serum Immunoglobulin Trough Levels Following Immunoglobulin..:

Berger, Mel ; Praus, Michaela ; Hofmann, Jutta.
Journal of Allergy and Clinical Immunology.  143 (2019)  2 - p. AB14 , 2019
Link: https://doi.org/10.1016/..
 
?
15

Treatment Satisfaction with Subcutaneous Immunoglobulin Rep..:

Mallick, Rajiv ; Jolles, Stephen ; Kanegane, Hirokazu..
Journal of Clinical Immunology.  38 (2018)  8 - p. 886-897 , 2018
Link: https://doi.org/10.1007/..
 
1-15